Review of the TAXUS® Liberte™ SR paclitaxel-eluting coronary stent

被引：8

作者：

Ahmed, Waqar Habib ^{[1
]}

机构：

[1] Armed Forces Hosp, Jeddah 21492, Saudi Arabia

来源：

EXPERT REVIEW OF MEDICAL DEVICES | 2007年 / 4卷 / 02期

关键词：

drug-eluting stents; paclitaxel; Taxus (R); restenosis; Liberte (TM);

D O I：

10.1586/17434440.4.2.117

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

The advent of drug-eluting stents has revolutionized the treatment of coronary heart disease. Interventional cardiologists are increasingly treating more complex lesions in patients that would have otherwise required bypass surgery. As a result of technological advances, the second-generation thin strut TAXUS stent - the TAXUS(R) Liberte(TM) SR paclitaxel-eluting coronary stent - has now been introduced into routine clinical practice. The Liberte stent has evolved from the currently available TAXUS Express(TM) stent to provide enhanced lesion access in challenging anatomies as well as more uniform drug delivery. This article will provide an overview of the TAXUS Liberte stent.

引用

页码：117 / 120

页数：4

共 22 条

[1] Twelve-month outcomes with a Paclitaxel-eluting stent transitioning from controlled trials to clinical practice (the WISDOM registry) [J].

Abizaid, Alexandre ;

Chan, Charles ;

Lim, Yean-Teng ;

Kaul, Upendra ;

Sinha, Nakul ;

Patel, Tejas ;

Tan, Huay-Cheem ;

Lopez-Cuellar, Julio ;

Gaxiola, Efrain ;

Ramesh, Saligram ;

Rodriguez, Alfredo ;

Russell, Mary E. .

AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (08) :1028-1032

[2]

AHMED WH, 2006, J INVASIVE CARDIOL, V18, P25

[3]

Axel DI, 1997, CIRCULATION, V96, P636

[4]

Blagosklonny MV, 2004, CELL CYCLE, V3, P1050

[5] The degree of neointimal formation after stent placement in atherosclerotic rabbit iliac arteries is dependent on the underlying plaque [J].

Carter, AJ ;

Farb, A ;

Gould, KE ;

Taylor, AJ ;

Virmani, R .

CARDIOVASCULAR PATHOLOGY, 1999, 8 (02) :73-80

[6] Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions [J].

Colombo, A ;

Drzewiecki, J ;

Banning, A ;

Grube, E ;

Hauptmann, K ;

Silber, S ;

Dudek, D ;

Fort, S ;

Schiele, F ;

Zmudka, K ;

Guagliumi, G ;

Russell, ME .

CIRCULATION, 2003, 108 (07) :788-794

[7] Molecular basis of restenosis and drug-eluting stents [J].

Costa, MA ;

Simon, DI .

CIRCULATION, 2005, 111 (17) :2257-2273

[8] Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial - Support for the use of drug-eluting Stents in contemporary clinical practice [J].

Dawkins, KD ;

Grube, E ;

Guagliumi, G ;

Banning, AP ;

Zmudka, K ;

Colombo, A ;

Thuesen, L ;

Hauptman, K ;

Marco, J ;

Wijns, W ;

Popma, JJ ;

Koglin, J ;

Russell, ME .

CIRCULATION, 2005, 112 (21) :3306-3313

[9] A RANDOMIZED COMPARISON OF CORONARY-STENT PLACEMENT AND BALLOON ANGIOPLASTY IN THE TREATMENT OF CORONARY-ARTERY DISEASE [J].

FISCHMAN, DL ;

LEON, MB ;

BAIM, DS ;

SCHATZ, RA ;

SAVAGE, MP ;

PENN, I ;

DETRE, K ;

VELTRI, L ;

RICCI, D ;

NOBUYOSHI, M ;

CLEMAN, M ;

HEUSER, R ;

ALMOND, D ;

TEIRSTEIN, PS ;

FISH, RD ;

COLOMBO, A ;

BRINKER, J ;

MOSES, J ;

SHAKNOVICH, A ;

HIRSHFELD, J ;

BAILEY, S ;

ELLIS, S ;

RAKE, R ;

GOLDBERG, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) :496-501

[10] Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions [J].

Grube, E ;

Silber, S ;

Hauptmann, KE ;

Mueller, R ;

Buellesfeld, L ;

Gerckens, U ;

Russell, ME .

CIRCULATION, 2003, 107 (01) :38-42

← 1 2 3 →